Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
Yes, endometrial CD8+ T cell levels may predict reproductive outcomes in recurrent implantation failure, with higher proportions above a threshold linked to better success.
Treatments for recurrent implantation failure that lack reported safety data in reviews include Treg-targeting strategies (e.g., immunometabolic reprogramming, CAR Tregs) and PRP…
Yes, acupuncture combined with embryo transfer significantly improves clinical pregnancy rates in recurrent implantation failure, based on a meta-analysis of 14 RCTs and…
Yes, magnetic sphincter augmentation devices can erode after sleeve gastrectomy, with a significantly higher erosion rate (3.8%) compared to non-bariatric populations (0.1%-0.3%).
Adults with systemic sclerosis often have reflux that acid reducers cannot stop because their esophagus and stomach muscles do not squeeze properly, causing acid to linger longer…
Routine lab indicators like C-reactive protein and erythrocyte sedimentation rate help predict coronary artery lesions in children with Kawasaki disease.
GLP-1 agents address eating disorders by targeting appetite and gut-brain signaling pathways that regulate food reward and intake.
Yes, machine-learning models can predict coronary artery lesions in children with Kawasaki disease, with some achieving high accuracy (AUC up to 0.95).
No, adding prednisolone to standard treatment did not significantly reduce coronary artery lesions at 1 month in newly diagnosed Kawasaki disease patients, according to a large…
Yes, complement pathways are involved in kidney transplant rejection, including antibody-mediated rejection, and may be targeted for therapy.
Doctors predict post-stroke cognitive impairment risk using clinical prediction models that combine factors like age, sex, blood biomarkers, and brain imaging findings.
High homocysteine levels are linked to post-stroke cognitive impairment, while the role of uric acid is mixed; neither is proven to directly cause it.
Yes, Xarelto (rivaroxaban) is FDA-approved to reduce stroke risk in nonvalvular atrial fibrillation and to treat deep vein thrombosis, making it effective for patients with both…
Erythropoiesis-stimulating agents (ESAs) reduce total heart failure hospitalizations and improve exercise tolerance in adults with chronic heart failure and anaemia, but do not…
Yes, Xarelto (rivaroxaban) is FDA-approved for treating deep vein thrombosis (DVT) and reducing the risk of recurrent DVT.
Cardiac MRI with contrast and bone scintigraphy are the best tests for distinguishing cardiac amyloidosis from other heart issues, with echocardiography as a useful first…
Yes, education can help lower your risk of DVT after orthopedic surgery. A meta-analysis found that patients who received education had about half the risk of developing DVT…
A 2024 trial found that adding Qishen Yiqi dropping pills to standard Western medicine improved clinical effectiveness and heart function in chronic heart failure patients.
Coping experiences for CHF patients and caregivers center on differing views of illness, emotional exhaustion, strained relationships, and a need for support to find new meaning.
Yes, the apical sparing ratio (ASR) can help detect cardiac amyloidosis, but it is not perfect—it has moderate accuracy and should be used alongside other tests.
No, alternative loop diuretics (torsemide, azosemide, piretanide) do not reduce hospitalizations compared to furosemide in chronic heart failure, based on a systematic review of…
Yes, biologic therapy significantly improves asthma control for patients with severe asthma, reducing exacerbations and improving symptoms and lung function.
Experts suggest clinical remission in severe asthma means no exacerbations, no oral corticosteroids, good symptom control, and stable or optimal lung function.
Lung function goals for severe asthma focus on achieving optimal individual FEV1 and maintaining stability, rather than normal values, as part of clinical remission.
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.